Characteristics of Antigens

The human body is constantly exposed to a wide range of biological and environmental substances that may influence its internal balance and overall health. To maintain protection against potentially harmful agents, the immune system possesses specialised recognition mechanisms that enable it to identify and respond to different molecular structures. Central to this process are antigens, which serve as important biological markers in the recognition and regulation of immune activities. An antigen is any substance that can be specifically recognised by antibodies or receptors of immune cells. Depending on its nature and interaction with the immune system, an antigen may also stimulate a specific immune response.

Antigens occur in diverse forms and possess different chemical compositions. They may consist of proteins, polysaccharides, lipids, nucleic acids or combinations of these substances. Their presence is particularly significant on the surfaces of microorganisms such as bacteria, viruses, fungi and parasites, where they contribute to the identification of these organisms by the host’s immune system. Antigens may also originate from environmental materials, foreign particles, toxins, transplanted tissues and other substances encountered by the body. Furthermore, certain molecules naturally present within the body can become targets of immune recognition under particular circumstances.

The interaction between antigens and the immune system is highly specific and depends on distinctive molecular regions known as epitopes or antigenic determinants. These regions provide the structural features through which antibodies and immune cell receptors recognise particular antigens. This specificity allows the immune system to distinguish between different foreign substances and, under normal conditions, differentiate them from the body’s own components. Such recognition forms an essential foundation for the coordinated activities of innate and adaptive immune defence.

Following antigen recognition, a series of immunological events may occur, including the activation of specialised immune cells, the production of antibodies, the release of signalling molecules and the development of immunological memory. These responses help the body identify, neutralise or eliminate substances associated with potential threats. However, not every antigen produces the same degree of immune activation, as its ability to stimulate a response depends on several factors, including molecular size, chemical composition, structural complexity, foreignness and the manner in which it is processed and presented to immune cells.

The biological importance of antigens extends beyond the body’s natural defence mechanisms. They form the scientific basis of vaccination, where selected antigenic materials are introduced to prepare the immune system for future encounters with particular infectious agents. Antigens are also fundamental to laboratory investigations, blood grouping, tissue compatibility testing, immunological diagnosis and the identification of specific diseases. Their study therefore provides valuable insight into the mechanisms through which the immune system recognises molecular structures, establishes protective responses and maintains biological stability.

Specific features of antigens

As aforementioned, antigens are substances recognized by the body’s immune system that can stimulate or react with specific immune components, such as antibodies and lymphocyte receptors. They are commonly found on bacteria, viruses, fungi, parasites and other foreign materials. Antigens play an important role in immune recognition, antibody production and the body’s defence against infections. 

Their ability to trigger immune responses depends on their chemical composition, molecular size, structural complexity and degree of foreignness. Molecules or substances referred to as antigens possess the following characteristics:

Foreignness (non-self recognition): Antigens are generally recognized as foreign substances by the immune system because their molecular structures differ from those naturally present in the body.

Molecular size: Most effective antigens have relatively large molecular sizes. Larger molecules are generally more capable of stimulating an immune response than smaller molecules.

Chemical nature: Antigens may consist of proteins, polysaccharides, lipids or nucleic acids. Among these, proteins are generally the most effective inducers of immune responses.

Structural complexity: Antigens often possess complex molecular structures that enable the immune system to recognize and distinguish them from other substances.

Specificity: Each antigen possesses particular regions called epitopes or antigenic determinants, which are specifically recognized by antibodies and immune cell receptors.

Immunogenicity: Antigens differ in their ability to stimulate an immune response, including antibody production and the activation of immune cells.

Degradability: Many antigens can be broken down into smaller fragments by antigen-presenting cells and displayed to T lymphocytes through major histocompatibility complex (MHC) molecules.

Antigenicity: Antigens possess the ability to bind specifically to antibodies or immune cell receptors, allowing them to participate in specific immune reactions (Figure 1).

Foreignness (non-self recognition)

Foreignness is the first and one of the most important characteristics of an antigen. For any substance to be recognized as an antigen or immunogen, it must possess molecular structures that are genetically foreign to the host. Upon entering the body, the substance must first be identified by the host’s immune system as non-self before it can trigger a specific and targeted immune response against the invading antigen.

Foreignness is one of the fundamental characteristics of antigens and refers to the ability of the immune system to distinguish substances originating outside the body from those naturally produced within it. The immune system possesses sophisticated recognition mechanisms that enable it to identify unfamiliar biological materials and respond appropriately to potential threats. These foreign substances are commonly referred to as non-self molecules, while the molecules naturally belonging to the body are classified as self-components.

Antigens may enter the body through different routes, including inhalation, ingestion, injection, or direct contact with contaminated surfaces and damaged tissues. They may also originate from infectious organisms such as bacteria, viruses, fungi, and parasites. Additionally, foreign antigens may be introduced through blood transfusions, organ transplantation, and exposure to certain environmental substances. Their presence provides an opportunity for the immune system to recognize unfamiliar molecular structures and initiate protective responses.

The recognition of foreignness involves specialized immune cells and molecular receptors that detect distinctive features on antigenic substances. Cells such as macrophages, dendritic cells, and B lymphocytes participate in identifying and responding to foreign materials. Antigen-presenting cells can capture foreign substances, process them into smaller fragments, and display these fragments to T lymphocytes. This interaction helps coordinate specific immune responses against the recognized antigen.

A major feature of foreign antigens is that their molecular structures differ from the normal components of the host organism. These structural differences may involve variations in protein sequences, carbohydrate arrangements, or other chemical properties. Such variations allow immune recognition systems to distinguish foreign molecules from familiar biological structures. However, foreignness alone does not guarantee that a substance will produce a strong immune response. Other factors, including molecular size, chemical complexity, dosage, and the route of entry, also influence its immunogenic potential.

The ability to distinguish self from non-self is essential for maintaining immune balance. Under normal physiological conditions, immune tolerance prevents the immune system from attacking the body’s healthy cells and tissues. When this regulatory mechanism fails, immune cells may mistakenly recognize self-antigens as foreign, potentially resulting in autoimmune disorders. Similarly, the immune system may recognize transplanted tissues as non-self and initiate rejection reactions.

Foreignness is an important determinant of antigen recognition and immune activation. It enables the immune system to identify unfamiliar biological materials, differentiate them from normal body components, and develop appropriate defensive mechanisms. This characteristic forms an essential foundation for understanding immune surveillance, infection control, vaccination, and the maintenance of immunological tolerance.

Molecular size or weight

Molecular size is one of the important physical characteristics that determines the ability of an antigen to stimulate an effective immune response. It refers to the overall size and molecular weight of a substance, which influence how easily the immune system can recognize, process, and respond to it. In immunology, molecular weight is commonly expressed in Daltons (Da), a unit used to measure the mass of atoms and molecules. Generally, substances with larger molecular sizes have a greater potential to function as effective immunogens than very small molecules.

Most highly immunogenic antigens possess relatively large molecular weights, particularly those with molecular masses above 10,000 Daltons. Such molecules are more likely to contain several antigenic determinants, also known as epitopes, which provide multiple sites for recognition by antibodies and immune cell receptors. The presence of different epitopes allows the immune system to identify various regions of the same antigen, thereby increasing the possibility of activating a specific immune response.

Large molecules also tend to possess more elaborate chemical structures, making them more suitable for recognition by different components of the immune system. For example, many bacterial proteins and complex polysaccharides have considerable molecular sizes and can stimulate immune responses when introduced into the body. Their structural features provide opportunities for immune recognition, antigen processing, and the subsequent activation of immune cells.

On the other hand, substances with very low molecular weights are generally poor immunogens because they may lack sufficient structural complexity and the necessary features to independently stimulate an immune response. Some small molecules, such as haptens, illustrate this limitation. Although they can bind specifically to antibodies, they cannot usually induce antibody production on their own. However, when attached to larger carrier proteins, they can acquire the ability to stimulate an immune response. Non-immunogenic substances such as amino acids are of a molecular size lesser than 1000 Daltons.

Molecular size also influences the interaction between antigens and antigen-presenting cells, which capture, process, and present antigenic materials to T lymphocytes. Larger protein molecules can provide peptide fragments for presentation through MHC molecules, contributing to the activation of adaptive immunity.

Molecular size alone does not determine the immunogenicity of an antigen. Its chemical composition, structural complexity, foreignness, and ability to undergo processing also contribute to the strength of the immune response. Therefore, molecular size is an important determinant of antigen effectiveness, as larger and structurally complex molecules generally possess greater immunogenic potential than smaller, simpler substances.

Chemical nature of antigens

The chemical nature of an antigen is one of the major factors influencing its ability to interact with the immune system and stimulate an immune response. Antigens are composed of different biological molecules, including proteins, carbohydrates, lipids and nucleic acids. However, these substances do not possess the same capacity to trigger immune reactions. Their immunological effectiveness depends largely on their molecular structure or heterogeneity, chemical composition, complexity and ability to be recognized by immune cells and antibodies.

Proteins generally demonstrate the highest immunogenic potential, while polysaccharides, lipids and nucleic acids exhibit varying degrees of antigenic activity depending on their structural organization and molecular associations. The complexity and conformation of an immunogen is determined by both the physical and chemical properties of the molecule. For example, monomeric/homopolymer protein molecules (i.e. protein molecules with only one composition) are less immunogenic than polymeric/heteropolymer proteins consisting of the primary, secondary, tertiary and quaternary structures of a protein molecule.

Proteins are regarded as the most effective and powerful antigens because of their complex molecular structures and diverse amino acid arrangements. They contain numerous antigenic determinants, also known as epitopes, which can be recognized by specific antibodies and immune cell receptors. Their structural diversity provides multiple sites for immune recognition, making them highly immunogenic. Examples of protein antigens include bacterial toxins, viral surface proteins, enzymes and certain components of microbial cell membranes. Most protein antigens can also be processed by antigen-presenting cells and presented to T lymphocytes, thereby initiating specific immune responses.

Polysaccharides are another important class of antigens. They consist of long chains of monosaccharide units arranged in different patterns and configurations. Their antigenic properties are associated with the arrangement of sugar molecules and the presence of distinctive chemical groups. Polysaccharide antigens are commonly found in bacterial capsules and cell walls. For example, the capsular polysaccharides of Streptococcus pneumoniae contribute significantly to its antigenic properties. Although some polysaccharides can stimulate antibody production independently, they generally produce T-cell-independent immune responses, particularly in young children.

Lipids generally possess limited immunogenicity when present alone. Their relatively simple structures and poor solubility in aqueous environments make them less effective at independently stimulating conventional immune responses. Nevertheless, certain lipids can function as antigens when associated with proteins or presented through specialized molecules. For instance, glycolipids contain carbohydrate components linked to lipid molecules and can be recognized by particular immune cell receptors. Some lipid antigens are presented to T lymphocytes through CD1 (cluster of differentiation) molecules rather than the conventional MHC pathway.

Nucleic acids, including DNA and RNA, are also generally weak antigens under ordinary conditions. Their repetitive chemical structures and limited ability to stimulate conventional antibody responses make them less effective immunogens when isolated. However, nucleic acids can become immunologically significant when associated with proteins or incorporated into larger molecular complexes. Certain DNA- and RNA-containing complexes can be recognized by immune receptors and may participate in autoimmune reactions.

The immunogenicity of an antigen can also be enhanced especially when they are coupled to substances that help to increase their structural complexity and thus their molecular size as well. Such substances that increase the immunogenicity of an antigen and thus enhance immune response to them are known as adjuvants. Some examples of adjuvants include saponins, calcium salts, aluminium salts, and lipopolysaccharides (LPS) amongst others. Adjuvants are generally structurally different compounds linked together to increase immune response to an antigen.     

Structural complexity of antigens

Structural complexity is an important characteristic of antigens that influences their ability to be recognized by the immune system and stimulate an immune response. It refers to the degree of variation, arrangement, and organization of the chemical components that make up an antigen. The more diverse and intricate the molecular structure, the greater the possibility that the immune system will identify different regions of the substance as foreign.

Antigens are composed of various chemical substances, including proteins, polysaccharides, lipids, and nucleic acids. Among these, proteins are particularly effective antigens because they possess complex three-dimensional structures and diverse amino acid sequences. Their structural arrangement provides multiple antigenic determinants, also known as epitopes, which can be recognized by specific antibodies and immune cell receptors. These distinct recognition sites contribute to the ability of a single antigen to interact with different components of the immune system.

The presence of different chemical groups within an antigen increases its structural diversity. Variations in molecular shape, size, surface arrangement, and chemical composition provide distinctive features that enable immune cells to differentiate between foreign substances. For example, a protein containing several different amino acid sequences is generally more capable of presenting multiple recognizable epitopes than a molecule with a simple and repetitive arrangement.

In contrast, substances with simple chemical structures and repetitive molecular patterns tend to possess fewer distinctive antigenic determinants. Consequently, they may produce a weaker immune response compared with structurally complex substances. However, structural complexity alone does not determine immunogenicity, as other factors, such as molecular size, foreignness, chemical composition, and the ability of antigen-presenting cells to process the substance, also contribute to immune stimulation.

The three-dimensional configuration of an antigen is equally significant because changes in molecular folding can influence the accessibility and recognition of its epitopes. When an antigen undergoes structural modification, certain recognition sites may become exposed, concealed, or altered, thereby affecting its interaction with antibodies and immune receptors. Structural complexity contributes significantly to antigen recognition by providing a variety of molecular features and antigenic determinants. It enhances the possibility of specific immune interactions and helps explain why complex proteins and other structurally diverse molecules often exhibit greater immunogenic potential than simple chemical substances.

Specificity (antigenic specificity) and epitopes

Antigenic specificity is a fundamental characteristic of antigens that enables the immune system to distinguish between different foreign substances and recognize particular molecular structures. Every antigen possesses distinctive regions known as epitopes or antigenic determinants, which are responsible for its specific interaction with components of the immune system. These regions determine how an antigen is identified and differentiated from other antigens during an immune response.

Epitopes are relatively small portions of an antigen that are specifically recognized and bound by antibodies, B-cell receptors (BCRs), or T-cell receptors (TCRs). They represent the precise sites through which immune recognition takes place. Although an antigen may consist of a large and complex molecular structure, only particular regions of its surface or internal composition participate directly in recognition by immune cells and antibodies.

Antigens bind to antibodies with the help of some intercellular forces such as Van der waals forces, hydrogen bonds and hydrophobic or electrostatic forces. Antibodies that fit and bind closely with antigens without dissociation are said to have high affinity. Affinity is the binding strength between a single receptor site on an antibody and a single epitope on an antigen. It is simply the strength of binding of an immunogen to an antibody. The overall strength of binding or interaction between an immunogen with many epitopes and a polyvalent antibody (e.g. IgM) is known as avidity.

As aforesaid, epitopes are the recognition and binding sites of an antigen that bind to antigen-specific receptors or secreted antibodies. A particular microorganism can have several epitopes to which antibody binds. For example, on the surface of a bacterium are found cell wall (O) antigen, capsular (vi) antigen, flagella (H) antigen, and a host of other antigenic sites that antibodies binds to specifically. Immunogens or antigens with multiple antigenic determinants are generally known to elicit various types of antibodies as well.

Antigenic specificity depends largely on the chemical composition, molecular arrangement, amino acid sequence, and three-dimensional configuration of these epitopes. The spatial organization of atoms within an epitope determines its distinctive molecular pattern, allowing it to interact with a complementary binding site on an antibody or immune receptor. This interaction is highly selective and follows the principle of structural and chemical compatibility.

A single antigen may contain several different epitopes, each capable of being recognized by a different antibody or immune cell receptor. Consequently, one antigen can stimulate the production of multiple antibodies with different specificities. This phenomenon contributes to the diversity and precision of the adaptive immune response.

Epitopes are broadly classified into two major categories: linear epitopes and conformational epitopes. Linear epitopes consist of a continuous sequence of amino acids, whereas conformational epitopes are formed by amino acids brought together through the folding of a protein into its three-dimensional structure. Antibodies can recognize either type, depending on the structural properties of the antigen.

In addition, antigenic specificity plays an essential role in distinguishing between closely related microorganisms, identifying foreign proteins, and targeting particular disease-causing agents. For example, different strains of the same bacterial species may possess distinct surface antigens with unique epitopes, enabling the immune system to differentiate between them.

The specificity of antigen-antibody interactions is also fundamental to immunological laboratory procedures, including enzyme-linked immunosorbent assay (ELISA), immunofluorescence, and rapid diagnostic tests. These techniques exploit selective molecular recognition to detect particular antigens or antibodies in biological samples. Antigenic specificity is determined by the distinctive molecular characteristics of epitopes, which provide the basis for selective immune recognition, accurate antigen identification, and the development of targeted immune responses.

Ability to induce an immune response (immunogenicity)

Immunogenicity refers to the ability of an antigen to stimulate the body’s immune system and initiate a specific immune response. It is an essential characteristic that determines how effectively a foreign substance can activate immune cells and promote the production of antibodies. Although many substances can be recognized by the immune system, not all possess the ability to trigger a strong immune response. Therefore, antigens vary considerably in their immunogenic potential, depending on their physical, chemical and biological properties.

A substance with high immunogenicity is capable of stimulating different components of the immune system, including B lymphocytes, T lymphocytes and antigen-presenting cells. When such a substance enters the body, it is recognized as foreign by the immune system. Antigen-presenting cells, such as macrophages and dendritic cells, capture and process the antigen into smaller fragments. These fragments are subsequently displayed on the cell surface through MHC molecules, allowing T lymphocytes to recognize them and become activated.

Following this recognition, activated helper T cells release chemical messengers known as cytokines, which coordinate and regulate subsequent immune activities. These signals encourage B lymphocytes to differentiate into plasma cells, which produce antibodies specifically directed against the stimulating antigen. Other immune cells may also become activated, contributing to the elimination of the foreign substance. In some cases, memory B and T cells are formed, enabling the immune system to respond more rapidly and effectively when exposed to the same antigen in the future.

The immunogenicity of an antigen is influenced by several important factors:

• Molecular size: Large molecules generally possess greater immunogenic potential than smaller molecules because they often contain more antigenic determinants that can be recognized by immune cells.

• Chemical complexity: Structurally complex substances, particularly proteins, are usually more immunogenic than simple chemical compounds because they provide diverse recognition sites.

• Degree of foreignness: Substances that differ considerably from the body’s natural components are more likely to be identified as non-self and stimulate an immune response.

• Chemical composition: Proteins and complex polysaccharides are generally effective immunogens, whereas simple lipids and nucleic acids usually have limited immunogenicity when present independently.

• Antigen processing: The ability of an antigen to undergo processing and presentation by antigen-presenting cells influences its capacity to activate T lymphocytes and initiate an adaptive immune response.

• Route of entry and dosage: The amount of antigen introduced into the body and its route of administration can influence the intensity and nature of the resulting immune response.

Immunogenicity determines the effectiveness of an antigen in stimulating immune defence mechanisms. Antigens with favourable molecular characteristics and sufficient foreignness generally produce stronger immune responses, whereas substances with limited immunogenic properties may generate weak responses or require association with carrier molecules to become effective immunogens.

Degradability and processability of antigens

Degradability and processability are important characteristics that determine how effectively an antigen can be recognised and utilised by the immune system. Degradability refers to the ability of an antigen to undergo enzymatic breakdown into smaller molecular fragments, while processability describes the capacity of immune cells to modify these fragments into forms suitable for antigen presentation. These properties are essential for the activation of adaptive immune responses, particularly T-lymphocyte-mediated immunity.

Antigens are primarily processed by specialised immune cells known as antigen-presenting cells (APCs), which include dendritic cells, macrophages and B lymphocytes. These cells capture foreign substances through different mechanisms, such as phagocytosis, endocytosis and receptor-mediated uptake. Following internalisation, the antigens are transported into intracellular compartments where specific proteolytic enzymes break down their complex molecular structures into smaller peptide fragments.

The resulting peptides are subsequently associated with MHC molecules. These molecules serve as specialised presentation structures that transport antigenic fragments to the cell surface for recognition by T lymphocytes. Antigens processed within intracellular vesicles are generally presented through MHC class II molecules to CD4+ helper T cells, whereas proteins processed through the cytosolic pathway are commonly presented by MHC class I molecules to CD8+ cytotoxic T cells. Dendritic cells can also present certain extracellular antigens through a mechanism known as cross-presentation.

The efficiency of antigen degradation and processing depends on several factors, including molecular composition, structural complexity, susceptibility to enzymatic action and the accessibility of cleavage sites. Antigens that are resistant to enzymatic degradation may undergo inefficient processing, thereby reducing their ability to stimulate certain T-cell responses. Appropriate degradation facilitates the generation of antigenic peptides required for effective immune recognition.

Degradability and processability contribute significantly to antigen presentation, T-cell activation and the development of specific immune responses. They also influence the overall immunogenic potential of foreign substances and play an essential role in the establishment of effective adaptive immunity.

Antigenicity (ability to bind immune receptors)

Antigenicity is the distinctive property of an antigen that enables it to interact specifically with antibodies, BCRs, or TCRs, depending on the nature of antigen recognition. It describes the capacity of a substance to bind selectively to components of the immune system and participate in specific immunological reactions. This characteristic is fundamental to immune recognition because it allows the body to distinguish and respond to particular molecular structures.

• Specific molecular interaction: Antigens possess distinct structural regions known as epitopes or antigenic determinants, which provide specific binding sites for antibodies and immune receptors. These interactions depend on the complementary arrangement of chemical groups, molecular shape, and surface characteristics of the antigen and its corresponding receptor.

• Selective binding capacity: An antigen interacts with particular antibodies or immune receptors rather than binding indiscriminately to all immune molecules. This selectivity accounts for the precision of antigen–antibody reactions and contributes to the specificity of adaptive immune responses.

• Recognition by antibodies: Antibodies recognize and attach to specific epitopes on antigens through non-covalent interactions, including hydrogen bonds, electrostatic forces, hydrophobic interactions, and van der Waals forces. Such binding may result in antigen neutralization, agglutination, precipitation, or activation of the complement system.

• Interaction with lymphocyte receptors: B-cell receptors can recognize intact antigens directly, whereas T-cell receptors generally recognize processed antigenic peptides presented on major histocompatibility complex (MHC) molecules. These recognition mechanisms initiate specific immune activities and contribute to the regulation of adaptive immunity.

• Existence of haptens: Haptens are small molecular substances that possess antigenicity but lack sufficient immunogenicity to independently provoke an immune response. They can bind specifically to antibodies or immune receptors but generally require attachment to a larger carrier protein to stimulate antibody production.

• Carrier-dependent recognition: When a hapten combines with a carrier protein, the resulting hapten-carrier complex can become immunogenic. The immune system recognizes the combined structure, enabling the development of a specific antibody response against the hapten.

• Role in immunological reactions: Antigenicity underlies several immune mechanisms, including antigen-antibody complex formation, pathogen recognition, toxin neutralization, and immune-mediated elimination of foreign substances.

Genetic makeup of the host organism

The genetic constitution of a host organism is also a fundamental determinant of the immunogenic potential of an immunogen. Genetic variations influence how effectively an individual’s immune system recognizes, processes and responds to foreign substances. Consequently, the magnitude of antibody production and T-lymphocyte activation may differ considerably among individuals, even when they are exposed to the same immunogen. Similarly, different strains within the same species may exhibit contrasting immune responses because of inherited differences in genes responsible for immune regulation and antigen recognition.

One important genetic factor is the MHC, known in humans as the human leukocyte antigen (HLA) system. These genes encode molecules responsible for presenting antigenic fragments to T lymphocytes. Variations in MHC genes determine which antigenic peptides can be effectively presented to immune cells, thereby influencing the strength and specificity of the resulting immune response. Individuals possessing different MHC variants may therefore respond differently to an identical immunogen. Other genetic factors, including genes controlling antibody production, cytokine secretion and immune-cell development, also contribute to individual differences in immunogenicity.

The ability of an immunogen to provoke an immune response is not determined by its intrinsic properties alone. The genetic background of the host interacts with several immunological and physiological factors, including the route of administration, dosage, age and general immune status. These variables collectively influence the extent to which the immune system recognizes and responds to the administered substance.

The route of administration is particularly important because it determines the tissues, immune cells and lymphoid organs initially exposed to the immunogen. Parenteral administration, such as intramuscular or subcutaneous injection, can facilitate antigen uptake by antigen-presenting cells and stimulate systemic immune responses. In contrast, administration through the alimentary canal exposes antigens to gastrointestinal immune mechanisms, which may promote immune tolerance rather than an aggressive immune reaction.

The quantity of immunogen administered influences the magnitude and quality of the immune response. An appropriate dose may stimulate effective immune activation, whereas an insufficient dose may produce a weak response and an excessively high dose may sometimes induce immune tolerance or other regulatory mechanisms. The genetic makeup of the host organism, together with the dosage and route of administration, plays a significant role in determining the intensity, specificity and overall effectiveness of an immune response to an immunogen.

References

Abbas A.K, Lichtman A.H and Pillai S (2010). Cellular and Molecular Immunology. Sixth edition. Saunders Elsevier Inc, USA.

Actor J (2014). Introductory Immunology. First edition. Academic Press, USA.

Alberts B, Bray D, Johnson A, Lewis J, Raff M, Roberts K and Walter P (1998). Essential Cell Biology: An Introduction to the Molecular Biology of the Cell. Third edition. Garland Publishing Inc., New York.

Barrett   J.T (1998).  Microbiology and Immunology Concepts.  Philadelphia,   PA:  Lippincott-Raven Publishers. USA.

Jaypal V (2007). Fundamentals of Medical Immunology. First edition. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India.

Levinson W (2010). Review of Medical Microbiology and Immunology. Twelfth edition. The McGraw-Hill Companies, USA.

Roitt I, Brostoff J and Male D (2001). Immunology. Sixth edition. Harcourt Publishers Limited, Spain.